company background image
524470 logo

Syncom Formulations (India) BSE:524470 Stock Report

Last Price

₹21.29

Market Cap

₹20.0b

7D

7.4%

1Y

132.9%

Updated

06 Nov, 2024

Data

Company Financials

Syncom Formulations (India) Limited

BSE:524470 Stock Report

Market Cap: ₹20.0b

524470 Stock Overview

Manufactures, markets, and sells pharmaceutical formulation products in India.

524470 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance5/6
Financial Health4/6
Dividends0/6

Syncom Formulations (India) Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Syncom Formulations (India)
Historical stock prices
Current Share Price₹21.29
52 Week High₹27.94
52 Week Low₹9.05
Beta1.4
11 Month Change8.79%
3 Month Change35.69%
1 Year Change132.93%
33 Year Change94.25%
5 Year Change2,985.51%
Change since IPO1,316.64%

Recent News & Updates

Recent updates

Shareholder Returns

524470IN PharmaceuticalsIN Market
7D7.4%1.5%0.2%
1Y132.9%54.6%35.3%

Return vs Industry: 524470 exceeded the Indian Pharmaceuticals industry which returned 54.6% over the past year.

Return vs Market: 524470 exceeded the Indian Market which returned 35.3% over the past year.

Price Volatility

Is 524470's price volatile compared to industry and market?
524470 volatility
524470 Average Weekly Movement10.3%
Pharmaceuticals Industry Average Movement6.2%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.3%
10% least volatile stocks in IN Market4.0%

Stable Share Price: 524470's share price has been volatile over the past 3 months compared to the Indian market.

Volatility Over Time: 524470's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Indian stocks.

About the Company

FoundedEmployeesCEOWebsite
1988998Vijay Bankdawww.syncomformulations.com

Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India. It operates through Manufacturing and Dealing in Pharmaceutical Drug & Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, gynae, opthal, ortho, and pediatrics formulations.

Syncom Formulations (India) Limited Fundamentals Summary

How do Syncom Formulations (India)'s earnings and revenue compare to its market cap?
524470 fundamental statistics
Market cap₹20.01b
Earnings (TTM)₹285.50m
Revenue (TTM)₹2.91b

70.1x

P/E Ratio

6.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
524470 income statement (TTM)
Revenue₹2.91b
Cost of Revenue₹1.76b
Gross Profit₹1.15b
Other Expenses₹864.12m
Earnings₹285.50m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Nov 11, 2024

Earnings per share (EPS)0.30
Gross Margin39.53%
Net Profit Margin9.82%
Debt/Equity Ratio25.2%

How did 524470 perform over the long term?

See historical performance and comparison